In last trading session, Core Scientific Inc (NASDAQ:CORZ) saw 4.86 million shares changing hands with its beta currently measuring 6.82. Company’s recent per share price level of $12.02 trading at -$0.37 or -2.99% at ring of the bell on the day assigns it a market valuation of $3.36B. That closing price of CORZ’s stock is at a discount of -54.99% from its 52-week high price of $18.63 and is indicating a premium of 78.29% from its 52-week low price of $2.61.
For Core Scientific Inc (CORZ), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.20. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.03 in the current quarter.
Core Scientific Inc (NASDAQ:CORZ) trade information
Upright in the red during last session for losing -2.99%, in the last five days CORZ remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $12.02 price level, adding 7.11% to its value on the day. Core Scientific Inc’s shares saw a change of -14.45% in year-to-date performance and have moved -1.96% in past 5-day. Core Scientific Inc (NASDAQ:CORZ) showed a performance of -19.87% in past 30-days.
Wall Street analysts have assigned a consensus price target of 16.5 to the stock, which implies a rise of 27.15% to its current value. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 24. It follows that stock’s current price would drop -16.47% in reaching the projected high whereas dropping to the targeted low would mean a loss of -16.47% for stock’s current value.
Core Scientific Inc (CORZ) estimates and forecasts
This year revenue growth is estimated to rise 1.63% from the last financial year’s standing.
13 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 97.06M for the same. And 8 analysts are in estimates of company making revenue of 107.16M in the next quarter. Company posted 141.93M and 179.29M of sales in current and next quarters respectively a year earlier.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 6.99 shares of worth $84.04 million or 2.50% of the total outstanding shares. The later fund manager was in possession of 5.0 shares on Nov 30, 2024 , making its stake of worth around $60.09 million in the company or a holder of 1.79% of company’s stock.
